University Hospital Birmingham NHS Foundation Trust

Birmingham B15 2TT

1 studies enrolling now · 7 studies all time

What they study most

Leiomyosarcoma, Lymphoma, T-Cell, Peripheral, Phenylketonuria (PKU), Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis, Propionic Acidemia, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia — Recruiting now
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling
• Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma — Running, not enrolling
• Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC) — Stopped early
• AAV Gene Therapy Study for Subjects with PKU — Running, not enrolling
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma — Completed